The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...

The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...

This is an important work implementing data mining methods on IMC data to discover spatial protein patterns related to the triple-negative breast cancer patients' chemotherapy response. The evidence ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with NSCLC, RCC, colorectal cancer ...

Thank you, Ashish, and good morning, everyone. This is a great example of the steps people in our business are willing to take to support their employees and manage events outside of their control.

After that, Pascal will provide a little more color on our fourth quarter performance, planned changes to our segment reporting next quarter, and key drivers of our financial guidance through 2028.

The DUB inhibitors market is poised for steady growth, driven by rising interest in targeted protein degradation and novel oncology therapeutics. The ...

There’s something magical about stepping into a place where time doesn’t just stand still—it’s actually for sale. Collinsville Antiques Co in New Hartford, Connecticut isn’t just an antique store; ...